Glipxen M 500 

Presentation:Glipxen M 500 is presented as tablets containing a fixed-dose combination of 2.5mg linagliptin and 500mg metformin hydrochloride.The tablets are usually film-coated and available in blister packs.The appearance (shape, color, markings) may vary depending on the manufacturer in Bangladesh (e.g., Beacon Pharmaceuticals PLC).

Indications:Glipxen M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metforminis appropriate.  

Dosage and Administration:The dosageof Glipxen M should be individualized based on effectiveness and tolerability, without exceeding the maximum recommended daily dose of 5mg linagliptin and 2000mg metformin. It is usually taken twice daily with meals to reduce gastrointestinal side effects associated with metformin.  

• For patients not currently on metformin: Initiate treatment with one tablet of Glipxen M 500 (2.5mg/500mg) twice daily with meals.
• For patients already on metformin: Start with one tablet of Glipxen M 500 twice daily, providing a similar total daily dose of metformin.
• Dose escalation should be gradual.

Follow your doctor's specific instructions regarding the dosage and timing of Glipxen M.

Side Effects: Common side effects may include diarrhea, nausea, vomiting, upset stomach, and headache. Nasal congestion, sore throat, and respiratory tract infections may also occur. When used in combination with insulin or sulfonylureas, there is an increased risk of hypoglycemia (low blood sugar).

Tell your doctor promptly if you experience any unusual or severe side effects, including symptoms of lactic acidosis (e.g., deep and rapid breathing, persistent nausea, vomiting, abdominal pain) or pancreatitis (severe abdominal pain).

Precautions:Glipxen M is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), metabolic acidosis, including diabetic ketoacidosis, and known hypersensitivity to linagliptin or metformin.It is not recommended in patients with active liver disease or excessive alcohol intake.

Caution should be exercised in patients with moderate renal impairment, heart failure, and a history of pancreatitis. Due to the metformin component, there is a risk of lactic acidosis, a serious metabolic complication.Temporary discontinuation of Glipxen M may be necessary in situations of dehydration, severe infection, or before surgery or certain radiological procedures involving iodinated contrast agents.

Monitor renal function before starting and periodically during treatment. Avoid excessive alcohol consumption.

The safety and efficacy of Glipxen M in children under 18 years have not been established. Use during pregnancy and breastfeeding should be carefully considered and is generally not recommended unless clearly needed.

Storage: Store Glipxen M tablets in a dry place, away from light and heat, below 30°C. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.